Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1981-06-19
1983-10-18
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Lymphokine
252307, 424244, A61K 3178, A01N 4300, B01J 1300
Patent
active
044105088
ABSTRACT:
A stable high expansion foam formulation for use as a single composite soion containing dibenz-(b,f)-1,4-oxazepine and stabilizers selected from the group consisting of glycerine, carboxyl vinyl polymers, and mixtures thereof. A method of using novel high expansion foam for visual obscuration and area denial is also disclosed.
REFERENCES:
patent: 1970578 (1934-08-01), Schoeller et al.
patent: 2971458 (1961-02-01), Kumins et al.
patent: 3210372 (1965-10-01), Werner et al.
patent: 3713404 (1973-01-01), Lavo et al.
patent: 3814808 (1974-06-01), Schwendeman et al.
patent: 4203974 (1980-05-01), Brown, Jr. et al.
Chem. Abstracts, 84:;13183w (1976).
Chem. Abstracts, 84:70014r (1976).
Brown, Jr. Harry A.
Durgin Robert F.
Erkkila A. Victor
Gibson Robert P.
Lane Anthony T.
Lovering Richard D.
The United States of America as represented by the Secretary of
LandOfFree
Novel aqueous foam formulation and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel aqueous foam formulation and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel aqueous foam formulation and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1289189